ASH 2023 | The impact of emicizumab on the hemophilia treatment landscape
Glaivy Batsuli
• 10 Dec 2023
In this video, Glaivy Batsuli, MD, Stanford University, Stanford, CA, briefly discusses the impact that emicizumab has had on the hemophilia treatment landscape, highlighting the considerable benefits that this agent has provided for patients with hemophilia A, both with and without inhibitors. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
